GHK-Cu – Injection

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper peptide complex formed by the tripeptide GHK and copper(II) ions. It belongs to the class of copper peptides, which are small bioactive peptides with a strong affinity for copper ions, playing important roles in cellular signaling and tissue repair. GHK-Cu is not an FDA-approved medication but is widely used in cosmetics, regenerative medicine, and compounding pharmacy for its reparative and anti-aging properties. It is primarily utilized for skin rejuvenation, wound healing, and anti-inflammatory purposes. Its therapeutic applications include improving skin elasticity, reducing fine lines and wrinkles, promoting collagen and glycosaminoglycan synthesis, enhancing angiogenesis (new blood vessel formation), and modulating gene expression to restore tissue health. Unlike traditional medications, GHK-Cu is a biomimetic peptide complex that differs from other anti-aging or wound healing agents by its ability to modulate multiple cellular pathways simultaneously, including growth factor expression, matrix metalloproteinase activity, and antioxidant defenses. This pleiotropic activity makes it unique compared to single-target drugs or topical agents. Key benefits for patients include: - Enhanced wound healing through stimulation of angiogenesis and collagen production. - Anti-inflammatory and antioxidant effects that protect and repair skin. - Improvement in skin firmness, elasticity, and clarity. - Reduction of hyperpigmentation and protection against UV damage. - Potential stimulation of hair growth and nerve regeneration. The general safety information of GHK-Cu is favorable, with low toxicity reported. It is naturally present in human plasma, saliva, and urine, and its levels decline with age, correlating with decreased regenerative capacity. Adverse effects are rare, but as with any peptide therapy, potential for local irritation or allergic reactions exists, especially with injectable formulations. From a compounding pharmacy perspective, GHK-Cu is typically formulated as a sterile injectable solution for intradermal or subcutaneous administration, or as a topical preparation in creams or serums. Key compounding considerations include: - Maintaining sterility and stability of the peptide-copper complex. - Using appropriate buffers and preservatives to preserve activity. - Ensuring correct concentration and pH to optimize bioavailability and minimize irritation. - Packaging in light-protective containers to prevent degradation. - Proper storage, usually refrigerated, to maintain potency. Formulations may vary depending on intended use (cosmetic vs. therapeutic), route of administration, and patient-specific factors. Compounding pharmacists must adhere to aseptic techniques and validate formulations for purity and potency. In summary, GHK-Cu is a naturally derived copper peptide complex with multifaceted regenerative and anti-aging effects, used primarily in compounding for skin and tissue repair applications. Its unique mechanism, safety information, and broad biological activity distinguish it from conventional medications, making it a valuable agent in personalized peptide therapy.

GHK-Cu (Glycyl-L-Histidyl-L-Lysine:Copper Complex): - Copper-binding peptide with powerful regenerative properties - Stimulates collagen and elastin production - Enhances angiogenesis (blood vessel formation) - Modulates metalloproteinases (tissue remodeling) - Anti-inflammatory effects - Antioxidant activity - Promotes stem cell activation

information

Well-Tolerated: No major adverse effects at standard doses

Common Side Effects (Minimal): - Injection site reactions (mild) - Transient redness with topical use - Rare: Metallic taste

Contraindications: - Copper sensitivity/allergy - Wilson's disease (copper metabolism disorder) - Hemochromatosis (consider copper load)

Immunogenicity Risk: Significant risk of immune response with peptide therapy. Monitor for hypersensitivity reactions.

Contraindications and Precautions for GHK-Cu (Copper Peptide):

• Pregnancy
• Lactation
• Known hypersensitivity to copper peptides

For compounding pharmacy use, GHK-Cu administration instructions involve careful preparation, dilution, compatible diluents, and proper administration techniques to ensure safety and efficacy. - Preparation/Reconstitution Steps: GHK-Cu is typically supplied as a lyophilized powder that must be reconstituted with sterile water for injection or bacteriostatic water. Use aseptic technique to add the appropriate volume of diluent to achieve the desired concentration. For example, if preparing a 1 mg/mL solution, add 1 mL of sterile water per 1 mg of GHK-Cu powder. Mix gently to avoid peptide degradation. Some protocols combine GHK-Cu with other peptides by drawing specified units of each into the same syringe after reconstitution. - Dilution Requirements: After reconstitution, further dilution may be required depending on the intended route (e.g., subcutaneous injection or intravenous Dilution should be done with compatible sterile diluents such as normal saline or bacteriostatic water. Concentrations for injection typically range from 0.1 mg/mL to 2 mg/mL, adjusted per prescriber instructions and patient tolerance. - Compatible Diluents: Sterile water for injection, bacteriostatic water, and 0.9% sodium chloride (normal saline) are compatible diluents. Avoid mixing with Vitamin C or acidic solutions simultaneously, as copper ions in GHK-Cu can counteract Vitamin C’s antioxidant effects. - Administration Technique: GHK-Cu is most commonly administered via subcutaneous injection. Use a sterile syringe and needle for injection. The injection site should be rotated to minimize local irritation. For topical use, apply as a cream or serum on clean skin, avoiding simultaneous application with Vitamin C products. - If used, dilute appropriately and infuse slowly over 15-30 minutes to monitor for adverse reactions. No standardized Subcutaneous injections are typically given as a single bolus dose. - Injection Site Recommendations: Preferred injection sites include the abdomen, thigh, or upper arm subcutaneous tissue. Rotate sites regularly to prevent irritation or lipodystrophy. Avoid areas with skin lesions or infections. - g., laminar flow hood) - Refrigeration for storage of reconstituted solution if not used immediately - Compounding-Specific Administration Notes: - Use aseptic technique throughout preparation and administration to prevent contamination. - Reconstituted GHK-Cu solutions should be used promptly or stored refrigerated and protected from light to maintain stability. - Avoid mixing GHK-Cu with incompatible substances in the same syringe unless validated. - Monitor patients for rare allergic reactions such as itching or hives after administration. - Document lot numbers, preparation times, and expiration dates per pharmacy compounding standards. In summary, GHK-Cu for compounding use requires reconstitution with sterile water or compatible diluents, subcutaneous injection with proper aseptic technique, rotation of injection sites, and careful handling to maintain peptide stability and patient safety. Avoid co-administration with Vitamin C products and follow prescriber-specific dosing and dilution instructions.